Study identification

EU PAS number

EUPAS1000000584

Study ID

1000000584

Official title and acronym

DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics

DARWIN EU® study

Yes

Study countries

Denmark
France
Germany
Netherlands
Norway
Spain
Sweden

Study description

Paracetamol (acetaminophen) is one of the most widely used medicines worldwide and is available over the counter in the European Union.
It is one of the most common causes of drug poisonings and can result in severe hepatic failure.
Different regulatory interventions at national level have occurred to reduce the incidence of paracetamol overdose, but it is uncertain how paracetamol is prescribed across Europe and to what extent prescription may be involved in poisonings.

Study status

Ongoing
Research institutions and networks

Institutions

Networks

Contact details

Berta Raventos

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
EMA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable